Meta Biomed Co. Ltd (059210) — Cash Flow Reinvestment Rate
Meta Biomed Co. Ltd (059210) has a Cash Flow Reinvestment Rate of 18.28x as of September 2025, reinvesting ₩19.27 Billion (capex ₩4.44 Billion plus investments ₩14.83 Billion) from operating cash flow of ₩1.05 Billion. Check Meta Biomed Co. Ltd (059210) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Meta Biomed Co. Ltd Cash Flow Reinvestment Rate (2011–2024)
Historical reinvestment intensity for Meta Biomed Co. Ltd across 11 annual periods. Explore 059210 long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Meta Biomed Co. Ltd (2011–2024)
Year-by-year capital reinvestment analysis for Meta Biomed Co. Ltd. For live market cap and broader valuation context, see 059210 market cap.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 2.41x | ₩54.47 Billion | ₩22.63 Billion | ₩11.10 Billion | ▲ +6.0% |
| 2023 | 2.27x | ₩23.20 Billion | ₩10.22 Billion | ₩11.49 Billion | ▼ -30.6% |
| 2022 | 3.27x | ₩29.98 Billion | ₩9.16 Billion | ₩15.41 Billion | ▲ +333.1% |
| 2021 | 0.76x | ₩8.42 Billion | ₩11.14 Billion | ₩2.07 Billion | ▼ -62.1% |
| 2020 | 1.99x | ₩9.69 Billion | ₩4.86 Billion | ₩2.23 Billion | ▼ -26.6% |
| 2019 | 2.72x | ₩7.78 Billion | ₩2.86 Billion | ₩7.56 Billion | ▲ +76.6% |
| 2016 | 1.54x | ₩7.74 Billion | ₩5.03 Billion | ₩6.13 Billion | ▼ -26.0% |
| 2015 | 2.08x | ₩10.25 Billion | ₩4.93 Billion | ₩7.79 Billion | ▲ +67.7% |
| 2013 | 1.24x | ₩4.60 Billion | ₩3.71 Billion | ₩4.60 Billion | ▼ -9.7% |
| 2012 | 1.37x | ₩5.26 Billion | ₩3.83 Billion | ₩5.26 Billion | ▼ -31.5% |
| 2011 | 2.00x | ₩8.22 Billion | ₩4.10 Billion | ₩8.22 Billion | — |